Pendergrast is an anesthesiology resident physician at the University of Michigan. The 1 in 5 Americans suffering from chronic pain may soon lose access to evidence-based interventions that have ...
Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
Interventional pain specialists warn spring activity aggravates back conditions and share how innovative regenerative ...
Current evidence on the efficacy of peripheral nerve-field stimulation (PNFS) for chronic low back pain is limited in both quantity and quality, and duration of follow-up is limited. Evidence on ...
Please provide your email address to receive an email when new articles are posted on . Multiple Medicare Administrative Contractors have proposed to restrict coverage for peripheral nerve block ...
SCOTTSDALE, AZ, UNITED STATES, February 13, 2026 /EINPresswire.com/ — Dr. Jordan S. Weiner, board-certified otolaryngologist and president of Valley ENT, has ...
Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced significant reimbursement milestones for its Freedom ® Peripheral Nerve Stimulator (PNS) System, ...
The vagus nerve stimulator (VNS) is a pacemaker-like device implanted in the chest that delivers intermittent electrical signals to the brain via an electrode wrapped around the left vagus nerve. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results